Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dicloxacillin on Oral Absorption of Drugs
NCT05073627Phase 1Completed
- Sponsor
- University of Southern Denmark
- Start
- Feb 2022
- Primary completion
- Jun 2022
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dicloxacillin in bacterial infection, sponsored by University of Southern Denmark. Primary endpoint: Area under the curve at Day 28. Started Feb 2022; status: completed.
02
Drugs
dicloxacillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05073627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073627.